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Neuraxial modulation for treatment of VT storm
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USA.
Abstract
In the hyperadrenergic state of VT storm where shocks are psychologically and physiologically traumatizing,
suppression of sympathetic outflow from the organ level of the heart up to higher braincenters plays a significant
role in reducing the propensity for VT recurrence. The autonomic nervous system continuously receives input from
the heart (afferent signaling), integrates them, and sends efferent signals to modify or maintain cardiac function and
arrhythmogenesis. Spinal anesthesia with thoracic epidural infusion of bupivicaine and surgical removal of the
sympathetic chain including the stellate ganglion has been shown to decrease recurrences of VT. Excess sympa-
thetic outflow with catecholamine release can be modified with catheter-based renal denervation. The insights pro-
vided from animal experiments and in patients that are refractory to conventional therapy have significantly
improved our working understanding of the heart as an end organ in the autonomic nervous system.
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Introduction
Ventricular tachycardia (VT) storm, defined as . 3
episodes of VT within a 24 hour period, has high mor-
bidity and mortality. VT storm is commonly managed
with antiarrhythmic therapy, treatment of reversal
causes (ischemia and electrolyte imbalance), and cathe-
ter ablation. Additionally, medical optimization of con-
comitant heart failure is necessary with pharmacologic
and/or mechanical support, as refractory arrhythmias
may be a symptom of decompensated pump function.
In the hyperadrenergic state of VT storm where shocks
are psychologically and physiologically traumatizing,
suppression of sympathetic outflow from the organ level
of the heart up to higher brain centers plays a significant
role in reducing the propensity for VT recurrence. For
this reason, sedation with general anesthesia is recom-
mended not only for reducing pain and morbidity from
shocks, but also physiologically decreases excessive
sympathetic tone.
The autonomic nervous system continuously receives
input from the heart (afferent signaling), integrates them,
and sends efferent signals to modify or maintain cardiac
function and arrhythmogenesis
[1]
(Fig. 1). In this review,
we discuss the rationale and evidence behind neuraxial
modulation for the treatment of VT with thoracic epidural
anesthesia, sympathectomy, and renal denervation.
Thoracic epidural anesthesia
For patients presenting with VT or ventricular fibril-
lation storm, b -blockers and other antiarrhythmics not
contraindicated are frequently used as primary therapy.
Sympathetic tone can be further reducedby intubation
and sedation and thoracic epidural anesthesia (TEA).
The institution of TEA can be performed at the bedside
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in standard fashion by anesthesiologists. In 2005,
intrathecal clonidine was shown to reduce ischemia-
induced ventricular arrhythmias in a canine model
[2]
.
In the same year, our group reported the successful
management of electrical storm with use of TEA. us-
ing 1 mL bolus 0.25% bupivacaine followed by
continuous infusion at 2 mL/hr at the T1-T2 interspace
confirmed with fluoroscopy
[3]
(Fig. 2). TEA is performed
via a paramedian approach using a 17 gauge Tuohy
epidural needle and a 19 gauge Flex-Tip plus epidural
catheter (Arrow International Inc, Reading, PA, USA).
No adverse hemodynamic changes were noted and
complete suppression of VT was observed prior to
catheter ablation. In our initial series of 8 patients that
underwent TEA, .80% burden in VT was observed
in 6 patients
[4]
(Fig. 3).
Sympathetic denervation and stellate
ganglionectomy
Efferent sympathetic preganglionic neurons that
regulate cardiac function reside within the intermediate
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Fig. 1 Cardiac sympathetic regulation via the autonomic nervous system with the heart as an end organ under multiple levels of
control. ACh: acetyl choline; LSG: left stellate ganglia; NE: norepinephrine; RSG: right stellate ganglia.
Fig. 2 Placement of thoracic epidural catheter for spinal anesthesia confirmed with contrast injection on fluoroscopy. Blue arrows
indicate contrast in epidural space.
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zone of the thoracic spinal cord at the level of T1-T4.
The sympathetic chain lies on either side of the verteb-
rae and consist of paravertebral ganglia and inter-
connecting nerves extending from the cervical to the
lumbar levels
[5]
.
Within the sympathetic chain, preganglionic axons
synapse on neurons within thestellate ganglion (fusion
of inferior cervical and T1 ganglia) and ganglia at
spinal levels T2-T4. The left and right stellate ganglia
(LSG and RSG) are the predominant ganglia from
which postganglionic fibers to the heart arise.
Sympathetic nerve fibers arrive at the base of the
heart, and penetrate the myocardium giving off smaller
branches that innervate the entire heart with intrinsic
cardiac ganglia as they extend to the apex. Denervation
with sympathectomy can be safely performed with
single-lung ventilation through a video assisted thora-
coscopic approach (Fig. 4).
Left cardiac sympathetic denervation (LCSD) inter-
rupts the major source of norepinephrine release in the
heart. Schwartz et al. demonstrated that LCSD
decreased the propensity for ventricular fibrillation in
an animal model of left anterior descending occlusion
[6]
.
A significant reduction in the number of recurrent
arrhythmias has been shown in a cohort of patients with
long-QT syndrome and catecholaminergic polymorphic
VT who received LCSD for secondary prevention
[7]
. In
our initial report, amongst 9 patients that underwent
LCSD, 5 patients had either complete or partial response
[4]
.
More recently, our group has been investigating the
physiologic and therapeutic differences between left
and bilateral sympathectomy
[8]
. Clinical reports of
bilateral cardiac sympathetic denervation (BCSD) to
treat severe ventricular arrhythmiasdate back to 1961,
described by Estes and Izlar
[9]
. In prior studies, stimulation
or resection of the RSG accelerated or slowed arrhythmias
originating from the right border of an anterior infarct
[10]
,
and RSG resection in a canine model of ischemia and
ventricular arrhythmias was as potent as LSG resection
reducing the incidence of ventriculararrhythmias
[11]
.
In our early experience, three of the six patients had
undergone previous LCSD but developed arrhythmia
recurrence. RCSD after prior LCSD was effective in
suppressing these arrhythmias. In a series of 6 patients,
4 patients had a complete response with BCSD and 1
patient had a partial response
[12]
.
With longer follow up, we found that patients that
underwent BCSD had significantly improved freedom
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Fig. 4 Thoracoscopic view of sympathetic chain with stellate ganglion and T2-T4 thoracic ganglia. Histopathologic confirmation of
neural tissue is performed postsurgically. Arrows in the right lower panel indicates ganglion. Arrow indicates ganglion cell.
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Fig. 3 Reduction in ventricular tachycardia (VT) burden pre
and post thoracic epidural anesthesia (TEA).
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from VT recurrence compared to those with unilateral
denervation
[13]
. Amongst 41 patients that underwent
CSD (14 LCSD, 27 BCSD), the number of ICD shocks
was reduced from a mean of 19.6 ¡ 19 preprocedure
to 2.3 ¡ 2.9 postprocedure (P , 0.001), with 90% of
patients experiencing a reduction in ICD shocks. At
mean follow-up of 367 ¡ 251 days postprocedure,
survival free of ICD shock was 30% in the LCSD group
and 48% in the BCSD group. Shock-free survival was
greater in the bilateral group than in the LCSD group
(P 5 0.04).
Renal denervation
Catheter-based renal denervation (RDN) is currently
being studied as a treatment option for drug-refractory
hypertension. Although the results from Symplicity-
HTN3trial did not meet the prespecified endpoint
[14]
,
post hoc analysis demonstrated that patients with more
extensive ablation, with higher BP preprocedurally,
non-African American, and non-use of vasodilators
may represent a subgroup more likely to derive clinical
benefit
[15]
. Ablation within the renal arteries, by altering
efferent and afferent signaling, has the potential to improve
blood pressure, as well as heart failure, atrial, and ventri-
cular tachyarrhythmias. By decreasing norepinephrine
spillover, the propensity for VT may be decreased.
Ablation is performed within the renal arteries from
proximal to the first bifurcation in a spiral fashion spar-
ing the ostium (Fig. 5). The renal nerves run on the
adventitia in a complex interlaced network, necessitat-
ing transmural lesions, although the precise location
and number of ablation lesions required is currently
not known. Contrary to electrophysiologic ablation, a
standardized endpoint has not reached consensus for
renal denervation, although blunting of a hypertensive
response with high frequency stimulation has been used.
Multiple case reports have highlighted the potential
role of renal denervation for the treatment of refractory
VT
[16,17]
. Ventricular fibrillation thresholds were decreased
in an animal model when surgical renal denervation was
performed
[18]
. In a multi-center case series of 4 patients
[19]
,
RDN was well tolerated acutely and demonstrated no
clinically significant complications during follow-up
of 8.8 ¡ 2.6 months (range 5.0-11.0 months). The
number of VT episodes was decreased from 11.0 ¡
4.2 (5.0-14.0) during the month before ablation to 0.3
¡ 0.1 (0.2-0.4) per month after ablation.
Neuraxial modulation has emerged as a promising
therapeutic strategy for patients with refractory ventri-
cular arrhythmias. Arrhythmogenesis requires a substrate
and a trigger and autonomics may largely account for
the timing of clinical presentation. The uniting patho-
physiologic basis for these interventions is suppression
of excessive sympathetic activation. In current practice,
TEA can be instituted by anesthesiologists and thoracic
sympathectomy via a minimally-invasive thoracoscopic
approach can be performed by thoracic surgeons. The
role of renal denervation warrants further study but
holds promise. The insights provided from animal
experiments and in patients that are refractory to con-
ventional therapy have significantly improved our
working understanding of the heart as an end organ in
the autonomic nervous system.
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